Evidence map›Paper›PMID 40649208›Full record

ArticleMolecules (Basel, Switzerland)2025

Enhanced Oxidation of Carbamazepine Using Mn(II)-Activated Peracetic Acid: A Novel Advanced Oxidation Process Involving the Significant Role of Ligand Effects.

Xue Yang, Hai Yu, Liang Hong, Zhihang Huang, Qinda Zeng, Xiao Yao, Yinyuan Qiu

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xue YangSchool of Ecological Environment and Urban Construction, Fujian University of Technology, Fuzhou 350118, China.
Hai YuSchool of Ecological Environment and Urban Construction, Fujian University of Technology, Fuzhou 350118, China.
Liang HongSchool of Mechanical and Automotive Engineering, Fujian University of Technology, Fuzhou 350118, China.
Zhihang HuangOrbusneich Medical Shenzhen Co. Ltd., Shenzhen 518000, China.
Qinda ZengFujian Special Equipment Inspection and Research Institute, Fuzhou 350008, China.
Xiao YaoSchool of Ecological Environment and Urban Construction, Fujian University of Technology, Fuzhou 350118, China.ORCID 0000-0002-0085-4861
Yinyuan QiuSchool of Mechanical and Automotive Engineering, Fujian University of Technology, Fuzhou 350118, China.

Funding

The Education Department of Fujian Province JAT210285the Fujian Provincial Natural Science Foundation 2022J05183, KY310611the Fujian University of Technology GY-Z23074, GY-Z20168, E0600591
6 · The paper itself

Abstract

In recent years, extensive attention has been paid to advanced oxidation processes (AOPs) with peracetic acid (PAA), a widely used disinfectant, using transition metal ions for the degradation of organic contaminants within water environments. Mn(II) has been widely used as an effective homogeneous transition metal catalyst for oxidant activation, but it has shown poor performances with PAA. Since the stability of manganese species can be enhanced through the addition of ligands, this study systematically investigated a novel AOP for the oxidation of carbamazepine (CBZ) using an Mn(II)/PAA system with several different ligands added. The reactive species were explored through UV-vis spectrometry, scavengers, and probe compounds. The results suggest that Mn(III)-ligand complexes and other high-valent Mn species (Mn(V)) were generated and contributed obviously toward efficient CBZ oxidation, while radicals like CH

Indexed as

complexing ligandshigh-valent Mn speciesorganic contaminantsperacetic acidwastewater treatment

Identifiers

PMID40649208
PMCPMC12250843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.